Brief: Vivos Therapeutics Announces Reverse Stock Split
26/10/2023 12:42
Oct 26 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT
* VIVOS THERAPEUTICS INC- ANNOUNCED THAT IT WILL EFFECT A
1-FOR-25
REVERSE STOCK SPLIT OF ITS ISSUED AND OUTSTANDING COMMON STOCK
* VIVOS THERAPEUTICS INC- REVERSE STOCK SPLIT TO BRING CO
INTO
COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT FOR CONTINUED
LISTING ON NASDAQ
Source text for Eikon: ID:nGNX3ds6qd
Further company coverage: VVOS.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth